References
- Eliopoulos G M, Gardella A, Moellering R C, Jr. In vitro activity of ciprofloxacin, a new carboxyquinolone antimicrobial agent. Antimicrob Agents Chemother 1984; 25: 331–335
- Andriole V T. Efficacy of ciprofloxacin in animal models of infection. Am J Med 82. Suppl 1987; 4A: 67–70
- Peterson L R. Animal models: the in-vivo evaluation of ciprofloxacin. J Antimicrob Chemother 1986; 18: 55–64, Suppl. D
- Pearson R D, Steigbigel R T, Davis H T, Chapman S W. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother 1980; 18: 699–708
- Brooks S JD, Lyons J M, Braude A I. Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats. Am J Pathol 1974; 74: 345–358
- Glauser M P, Lyon J M, Braude A I. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest 1978; 61: 403–407
- Thauvin C, Eliopoulos G M, Willey S, Wennersten C, Moellering R C, Jr. Continuous infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrob Agents Chemother 1987; 31: 139–143
- Anhalt J P. Assays for antimicrobial agents in body fluids. Manual of clinical microbiology, E H Lennette, A Balows, W J Hausler, Jr, H J Shadomy. American Society for Microbiology, Washington 1985; 1009–1014
- Glauser M P, Ransley P, Bille J. Urinary tract infections, pyelonephritic scars and chemotherapy. Experimental models in antimicrobial chemotherapy, O Zak, M A Sande. Academic Press, London 1986; 319–346
- Herscovici L, Grise G, Thauvin C, Lemeland J F, Fillastre J P. Efficacy and safety of once daily versus intermittent dosing of tobramycin in rabbits with acute pyelonephritis. Scand J Infect Dis 1988; 20: 205–212
- Bille J, Glauser M P. Prophylaxis of pyelonephritis by aminoglycosides accumulated in the kidney. J Antimicrob Chemother 1981; 8: 115–119, Suppl A
- Marre R, Tietgen K, Himmelskamp M, Boness J, Sack K (1985) Ciprofloxacin and cefotaxime in experimental acute and chronic pyelonephritis. 1st international ciprofloxacin workshop. 1985, H C Neu, H Weuta. Proceedings Excerpta Medica, Leverkusen, 91–94
- Inoue M, Mitsuhashi S. In vitro and in vivo antibacterial activities of BAY O 9867. 14th International Congress of Chemotherapy. Kyoto 1985
- Peerbooms P GH, MacLaren D M. Comparative activities of five antimicrobial agents in experimental Proteus pyelonephritis. 14th International Congress of Chemotherapy. Kyoto 1985
- Herscovici L, Grise G, Thauvin C, Fillastre J P, Lemeland J F. Comparaison de l'efficacité de la ceftriaxone en injection quotidienne unique par rapport aux injections fractionnées dans le traitement des pyélonéphrites aiguës expérimentales. Pathol Biol (Paris) 1987; 35: 853–856